Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001035704-00-000167
Filing Date
2000-03-14
Accepted
2000-03-14 00:00:00
Documents
8
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD ENDING 12-31-99 10-K 203894
2 EIGHTH AMENDED AND RESTATED BYLAWS EX-3.2 83999
3 NON-EMPLOYEE DIRECTOR STOCK INCENTIVE PLAN EX-10.7 61628
4 PERSONAL SERVICES AGREEMENT -- DAVID R. BETHUNE EX-10.12 24281
5 AGREEMENT DATED AUGUST 2, 1999 -- JOHN E. URHEIM EX-10.13 27066
6 SUBSIDIARIES OF THE REGISTRANT EX-21 336
7 CONSENT OF DELOITTE & TOUCHE LLP EX-23 604
8 FINANCIAL DATA SCHEDULE EX-27 2042
  Complete submission text file 0001035704-00-000167.txt   406175
Mailing Address 2579 MIDPOINT DR FORT COLLINS CO 80525
Business Address 2579 MIDPOINT DR FORT COLLINS CO 80525 3034825868
ATRIX LABORATORIES INC (Filer) CIK: 0000809875 (see all company filings)

EIN.: 841043826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-18231 | Film No.: 568660
SIC: 2834 Pharmaceutical Preparations